Related Experiment Video
Updated: Jan 13, 2026

08:10
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
Published on: August 23, 2024
5.9K
Unique Aerofoil-Structured Microfluidics for High Throughput Lipid Nanoparticle Formulation Screening and Scale-up
Dongsheng Liu1,2,3, Mingzhi Yu1, Yuguo Zhang1
1Centre of Micro/Nano Manufacturing Technology (MNMT-Dublin), School of Mechanical & Materials Engineering, University College Dublin, Dublin, D04 V1W8, Ireland.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|October 28, 2025
Summary
This study introduces a novel microfluidic platform for rapid screening and scalable production of high-quality lipid nanoparticles (LNPs). The system optimizes LNP formulation and manufacturing for diverse applications.
Area of Science:
- Biotechnology and Biomedical Engineering
- Nanotechnology
- Chemical Engineering
Background:
- Lipid nanoparticles (LNPs) are crucial for nucleic acid delivery but face challenges in formulation screening and scale-up.
- Existing methods often require large reagent volumes and lack high-throughput capabilities.
Purpose of the Study:
- To develop a high-throughput microfluidic platform for efficient LNP formulation screening and seamless scale-up.
- To address limitations in mixing efficiency and LNP quality control during LNP production.
Main Methods:
- Design of micromixers with aerofoil structures for enhanced mixing across a wide flow rate range (0.2-50 mL min⁻¹).
- Development of a high-throughput screening instrument (MiNANO-form) with parallel microfluidic channels.
- Implementation of a modular microfluidic unit (MiNANO-scale) for continuous, scalable LNP production.
Main Results:
- Achieved consistent LNP formation with sizes ranging from 38-150 nm and polydispersity index (PDI) < 0.2.
- Demonstrated high-throughput screening using minimal reagent volumes (as low as 0.1 mL).
- Validated scalable production up to liter-scale (50 mL min⁻¹) and successful transfection/uptake studies in various cell lines.
Conclusions:
- The developed microfluidic platform enables rapid optimization and scalable manufacturing of high-quality lipid nanoparticles.
- This technology significantly advances LNP formulation and production for therapeutic applications.
- The platform's versatility is confirmed by successful mRNA, pDNA, and siRNA delivery studies.

